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COVID-19 has affected all countries globally. We explore associations between
the change in new COVID-19 registered cases per million population and various
macroeconomic and well-being indicators in 38 European countries over a 2-month
period (1st April-31st May 2020). A statistically significant (p = 0.002) negative
association was estimated between the change in new COVID-19 cases and GDP
per capita, after controlling for key health determinants including public expenditure on
health, life expectancy, smoking tobacco and sanitation. The country with the highest
GDP per capita in Europe (i.e., Luxemburg) was found to experience the lowest change
in newCOVID-19 cases within the time period whilst the opposite was found for countries
with lower GDP per capita (i.e., Ukraine, Bulgaria, and Romania). The outcomes of this
study indicate that, in the first wave of the pandemic in Europe, a country’s GDP per capita
might be associated with a lower rate of new COVID-19 cases. The study concludes by
suggesting that in European regions a country’s economic performance should be a
critical health priority for policy makers.
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INTRODUCTION
The global pandemic caused by COVID-19 has affected every county in the world (1). Various
factors have been shown to influence the rate of change of infection caused by SARS CoV-2-
s as confirmed by the daily change in new cases and of mortality. Individual and demographic
factors including older age (2, 3), male gender (4), socio-economic conditions (5), underlying
health co-morbidities (6), ethnicity (7, 8), smoking (9, 10) and obesity (11) have been identified
as significant influencing factors in the spread and mortality due to COVID-19. However, it has to
be recognized that these individual factors are likely to be influenced by various country specific
parameters including lockdown policies (12), public expenditure in health (13) and other country-
specific determinants such as level of sanitation (14), healthcare support i.e., number of acute care
beds, hospital beds and number of physicians; (15), and social support (16). Grima et al. (17)
indicated that monitoring of demographic features, country’s activity features, economic exposure
and societal vulnerability could help a country strengthen its capacity to meet the economic, social
and in turn healthcare demands due to pandemic hazards such as COVID-19.
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In poorer countries, households experience tighter budgets
and worse economic struggles (18, 19), resulting in poor
physical and mental health and decreased life expectancy
(18, 20). One of the most well-known illustrations of the
relationship between economic conditions and population
health is the Preston curve (21) which demonstrates that
people in richer countries, on average, live longer than in
poorer countries. Evidence indicates that a country’s economic
performance and fair income distribution results in an increase
in life expectancy, and a decrease in adverse health outcomes
and mortality rates (22). Theoretical insights indicate that
countries with higher GDP rates are able to provide their
people with better living standards, public health programs,
education and environmental sanitation all leading to enhanced
prevention, treatment of disease, better health and life expectancy
(17, 22–26).
In the US, GDP and economic growth were found to be
related to a decline in mortality rate between 1901 and 2000
(27). In OECD countries, for a period ranging from 1820 to
2001, GDP and GDP per capita were estimated to have a
significant positive influence on life expectancy (28). In Europe,
longitudinal studies, review studies and meta-analyses indicate
that reductions in GDP, national health system budgets and
households’ income are associated with adverse health outcomes
and deterioration in people’s well-being (29–31). The Great
Recession studies re-highlighted the positive associations of
economic prosperity and adequate national health provision to
better health outcomes (29–31). In Europe, since 1950, the rapid
economic growth brought a degree of prosperity which enabled
effective national health systems to be established, new drugs
and medical technologies to be developed that brought several
infections and diseases under control (32). However, better
health systems, cutting-edge medical technologies and drugs
required substantial funding (32). Within the World Health
Organization (WHO) European regions, for a period ranging
from 1900 to 2008, life expectancy was shown to be dependent
on economic activity, and mortality from cardiovascular diseases
were mainly attributable to changes in national income (23).
These patterns have been found in other diverse settings. For
instance, a recent study of young population groups in 103
low and middle-income countries showed that higher GDP
was inversely associated with all-cause, communicable and non-
communicable disease mortality both in males and females
(33). A study examining empirical assessments for 17 European
countries between 1970 and 2010, demonstrated that countries
with higher national income, higher health care expenditure,
higher quality of government, and higher social transfers have
smaller inequalities in mortality (34).
Given the presented theoretical considerations and empirical
findings, we hypothesize that poorer countries in Europe,
characterized by a lower economic performance, and limited
health and fiscal capacities of governments might underperform
in tackling the COVID-19 pandemic. Restricted personal and
family income, and inadequate public support for critical health
services could affect health prevention and the quality and
quantity of services experienced during the pandemic. In the US,
those affected more by COVID-19 were living in poorer regions,
had lower access to healthcare, experienced intergenerational
poverty, and had a higher prevalence of underlying health
conditions (35, 36). A recent study utilizing data from 188
countries found that COVID-19 has mainly affected vulnerable
population groups with underlying health conditions (37).
Although GDP per capita is one of the most widely used
covariates in health research (38), most current papers on
COVID-19 have focused on individuals’ socio-economic and
health characteristics (35–37). However, there are few exceptions.
Roy (39) presented a diagrammatic reasoning demonstrating a
negative relationship between the total number of COVID-19
cases and GDP per capita. On the other hand, Gangemi et al.
(40) found a moderate positive correlation between COVID-
19 cases and GDP per capita as did Lippi et al. (41) who
showed a positive correlation between COVID-19 mortality and
GDP per capita. The studies suggested that industrial pollution,
airplane connections, obesity and social events, which are higher
in developed regions, might have driven the positive correlations
(40, 41).
The aim of the present study is to explore correlations and
associations between the change in new COVID-19 cases per
million population, in the initial wave of the pandemic, obtained
on two dates that were 2 months apart (1st April and 31st
May 2020), and macroeconomic and well-being indicators in
38 European countries. In this study we indicate that the total
number of COVID-19 cases may not be the right indicator to
be utilized because case zero of COVID-19 case differs in each
country as the pandemic affected regions at different times. In
addition, we hypothesize that the change in new COVID-19 cases
per million population might be more detrimental in regions
where prior to the pandemic, people were experiencing worse
health due to greater economic hardships and insecurity.
The present paper is among the first studies to offer
multivariate regressions controlling for key heterogeneities and
assess associations between GDP per capita and change in new
COVID-19 cases in European regions in the first wave of the
pandemic. The outcomes of the study will show (i) a negative
correlation between the change in new COVID-19 cases per
million population and GDP per capita, public expenditure on
health, sanitation facilities and life expectancy at birth, and (ii) a
positive correlation between the change in new COVID-19 cases
and tobacco smoking. Moreover, the study’s outcomes will reveal
a negative association between the change in new COVID-19
cases per million population and GDP per capita after controlling
for critical health heterogeneities. The study will conclude that
in Europe a country’s prosperity, as it is captured by GDP per
capita, might be associated with a reduction in new COVID-
19 cases within the study’s time period. The assigned patterns
will indicate that better economically performed countries might
be able to respond to a health crisis and therefore a country’s
economic growth and development should be of importance.
Indeed, the study will present that the best performing
European country in terms of GDP per capita (i.e., Luxemburg)
experienced the lowest change in new COVID-19 cases per
million population.
The rest of the paper is structured as follows. In the next
section we describe the data set and methodology. Then, we offer
a correlation and regression analysis. The last section offers a
discussion and conclusions.
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MATERIALS AND METHODS
In this study data on the change in new COVID-19 cases per
million population were obtained for 38 European countries,
as some of the European data required for correlation and
multivariate analyses were only available for certain countries1.
In June 2020, COVID-19 data were extracted from Roser et al.
(42) which is a publicly available data set.
Keymacroeconomic andwell-being indicators for the targeted
European countries were considered after reviewing major
socio-epidemiological surveys (14, 22, 29, 37). These variables
constitute critical health determinants such as GDP per capita,
smoking tobacco, sanitation facilities, alcohol consumption,
acute care and total number of hospital beds (22). The variables
were extracted from major publicly available data sets2. For
each parameter, the last recorded year’s entry was used for
each country (if relevant information was available). As the
study utilized publicly available data, ethical clearance was
not required.
We indicate that while previous studies have compared
the total number of COVID-19 cases per million population
registered on a certain date, this approach might be inaccurate
as different European countries reported their first COVID-19
case at different times and therefore some European countries
would probably show higher prevalence compared to others. In
the present study we calculate the change in the numbers of new
COVID-19 cases between two dates, which were 2 months apart,
i.e., 1st April and 31st May 2020. As an example, the change of
new COVID-19 cases in the UK within the study’s time period is
−1,405 COVID-19 cases (42).
RESULTS
The empirical specification of this study consists of two parts.
In the first part, we present a correlation analysis, also used
by Gangemi et al. (40) and Lippi et al. (41), between the
change in new COVID-19 cases per million population and
11: Albania; 2: Andorra; 3: Austria 4: Belgium 5: Bosnia and Herzegovina; 6:
Bulgaria; 7: Croatia; 8: Cyprus; 9: the Czech Republic; 10: Denmark; 11: Estonia; 12:
Finland; 13: France; 14: Germany; 15: Greece; 16: Hungary; 17: Iceland; 18: Ireland;
19: Italy; 20: Latvia; 21: Lithuania; 22: Luxemburg; 23: Malta; 24: Montenegro; 25:
the Netherlands: 26: Norway; 27: Poland; 28: Portugal; 29: Romania; 30: Russia;
31: Serbia; 32: Slovakia; 33: Slovenia; 34: Spain; 35: Sweden; 36: Switzerland; 37:
Ukraine; 38: the United Kingdom.
2Gross Domestic Product per capita and extreme poverty: https://ourworldindata.
org/coronavirus;
Public expenditure on health: http://dmt.euro.who.int/classifications/tree/A;
Prevalence of obesity: https://gateway.euro.who.int/en/indicators/h2020_9-
obesity/;
Prevalence of overweight: https://gateway.euro.who.int/en/indicators/h2020_6-
overweight/;
Availability of social support: http://dmt.euro.who.int/classifications/tree/A;
Smoking prevalence: http://dmt.euro.who.int/classifications/tree/A;
Alcohol consumption: http://dmt.euro.who.int/classifications/tree/B;
Life expectancy at birth: http://dmt.euro.who.int/classifications/tree/B;
Sanitation facilities: http://dmt.euro.who.int/classifications/tree/B;
Acute care and total number of hospital beds: http://dmt.euro.who.int/
classifications/tree/A;
Practicing physicians: http://dmt.euro.who.int/classifications/tree/L.
macroeconomic and well-being indicators. Given the nature
of the variables (continuous) Pearson correlation coefficients
are reported. In the second part, we offer an OLS regression
analysis assessing the determinants of change in new COVID-
19 cases per million population. The regressions control for
critical determinants of COVID-19 disease (35–37). These are
GDP per capita, public expenditure on health, life expectancy
at birth, smoking tobacco, and sanitation facilities. In the
regression analysis, the main interest is to assess whether GDP
per capita is associated with the change in new Covid-19 cases
per million population. If GDP per capita remains statistically
significant after controlling for key covariates, then this feature
might indicate an association between the change in new
COVID-19 cases per million population and countries’ economic
performance in the specified region and period.
In this study we highlight that the regression outcomes should
be interpreted as associations and not as causal effects. It is well-
documented in the literature that a two-way relationship between
a country’s performance and good health might exist (22) due
to the fact that health may actually drive economic performance
(28, 31).
Correlation and Regression Outcomes
Correlation Analysis
Table 1 shows correlation coefficients for the change in new
COVID-19 cases per million population. Statistically significant
negative correlations were obtained between the change in
new COVID-19 cases and GDP per capita, public expenditure
on health, sanitation facilities and life expectancy at birth.
The outcomes indicate a country’s higher prosperity (GDP per
capita), public spending on health, and well-being indicators
(such as sanitation infrastructures and life expectancy at birth)
is associated with a lower change in new COVID-19 per million
population. A statistically significant positive correlation between
the change in new COVID-19 cases and tobacco smoking is
also found, indicating that smoking prevalence might deteriorate
health status and/or be an underlying health co-morbidity.
Figure 1 presents a negative correlation between the change
in new COVID-19 cases per million population and GDP per
capita. The figure indicates that Luxemburg which was the best
performing European country in terms of GDP per capita also
experienced the lowest change in new COVID-19 cases per
million population. On the other hand, countries facing lower
GDP per capita, such as Ukraine, Bulgaria, Romania and Russia,
experienced a higher level of change in new COVID-19 cases per
million population. The country with the highest level of change
in new COVID-19 cases per million population, within the time
period, was Russia.
Regression Outcomes
Table 2 presents the regression outcomes. We include only those
variables that were found to be statistically significant with the
change in new COVID-19 cases in Table 1 (i.e., GDP per capita,
public expenditure on health, life expectancy at birth, smoking
tobacco and sanitation facilities).
Panel I controls for public expenditure on health. The
estimates indicate that GDP per capita is negatively associated
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TABLE 1 | Correlation coefficients between the change in new COVID-19 cases
per million population and socio-epidemiological determinants over a two-month
period (1st April 2020 and 31st May 2020).
Panel I Number of
Change in new countries
COVID-19 cases
per million population
GDP per capita −0.665 (0.001)*** 37a
Extreme poverty 0.135 (0.503) 27b
Public expenditure on health −0.557 (0.001)*** 38
Obesity 0.077 (0.644) 38
Overweight −0.194 (0.314) 29c
Social support −0.252 (0.126) 38
Smoking tobacco 0.344 (0.035)** 38
Alcohol −0.127 (0.453) 37d
Life expectancy at birth −0.565 (0.001)*** 38
Sanitation facilities −0.409 (0.012)** 37e
Acute care beds 0.210 (0.212) 37f
No of Hospital beds 0.231 (0.162) 38
Median Age 0.032 (0.849) 37g
No physicians −0.058 (0.731) 37h
Pearson correlation coefficients are reported. p-values are in parentheses.
aAndorra is excluded due to data unavailability.
bAndorra, Cyprus, the Czech Republic, Finland, France, Germany, the Netherlands,
Poland, Serbia, Slovenia, and Switzerland are excluded due to data unavailability.
cBulgaria, Croatia, Germany, Lithuania, Luxemburg, Spain, Sweden, Switzerland and the
United Kingdom are excluded due to data unavailability.
dGermany is excluded due to data unavailability.
eMontenegro is excluded due to data unavailability.
fBosnia and Herzegovina is excluded due to data unavailability.
gAndorra is excluded due to data unavailability.
hSlovakia is excluded due to data unavailability.
***Statistically significant at the 1%. **Statistically significant at the 5%.
with the change in new COVID-19 cases per million population
at the 1% level. In Panel II, we control also for life expectancy
at birth and smoking tobacco. The new estimates continue to
indicate a negative association between GDP per capita and the
change in new COVID-19 cases per million population at the 1%.
In Panel III, we add controls for sanitation facilities. It is found
that GDP per capita continues to be negatively associated with the
change in new COVID-19 cases per million population at the 1%.
DISCUSSION
The aim of the study was to examine correlations between
the change in new COVID-19 cases per million population
and macroeconomic indicators, well-being indicators
and healthcare systems’ capacity in the first wave of the
COVID-19 pandemic. Most recent studies have focused on
demographic, socio-economic and health characteristics and
the COVID-19 pandemic (2, 6, 7, 17). In this study we were
particularly interested in assessing whether countries’ economic
performance, as it is captured by GDP per capita, might be
associated with COVID-19 spread in 38 European countries, in
the early stages. By extracting data in June 2020 and calculating
the change in new COVID-19 cases over a 2-month period,
between 1st April and 31st May 2020, univariate correlation
analysis indicated that new COVID-19 cases per million
population were (i) negatively correlated with GDP per capita,
public expenditure on health, sanitation facilities and life
expectancy at birth and (ii) positively correlated with tobacco
smoking. The adjusted regression analysis shows a significant
negative association between the change in new COVID-19
cases per million population and GDP per capita. The outcomes
of this study are in line with the limited research indicating
that COVID-19 cases are negatively associated with public
expenditure in health and health care infrastructure and capacity
(13, 15), sanitation (14) and positively associated with smoking
habits (9, 10).
The study contributes to the literature by assessing both
correlations and associations between COVID-19 and GDP per
capita. While recent studies have examined associations between
COVID-19 and individuals’ income (35–37), there is little
information assessing a country’s economic performance with
COVID-19 cases (39). Our study shows a negative relationship
between the change in new COVID-19 cases and GDP per
capita, in the first wave of the pandemic. We indicate that
GDP per capita differences among European countries might
reflect existing structural and economic factors (18). People living
in European countries with lower GDP per capita might have
poorer access to health services and have lower income resulting
in poorer health (31). These factors might be exaggerated during
periods of severe health and economic crises, negatively affecting
the less developed regions (31).
Prior to the pandemic, socio-epidemiological research
indicated positive associations between a country’s economic
performance and better health (22, 27, 28, 34), as well as positive
associations between individuals’ income and health status
(18, 20). In the present study we indicate that a wealthier country
might be able to provide their people with better living standards,
public health and environmental sanitation, leading to enhanced
prevention and disease treatment (22–24).
The last fifty years, European countries have experienced a
massive economic growth that have enabled them to invest in
health and develop effective health systems and brought several
infections and diseases under control (22, 24, 32). We should
note that a country’s economic performance not only determines
health systems’ capacity and effectiveness but also its labormarket
and vocational relations within the country. It is possible that
in advanced European countries, lockdowns to save lives might
be easier since a greater number of people work in sectors
where information technology infrastructure enables them to
work from home (43). This might be challenging in poorer
European countries where a greater number of people work in
sectors where manual labor is needed (43). Such jobs make up
the new COVID-19 essential workforce i.e., food service workers,
bus drivers.
There are a number of limitations in the present study. It is
possible that a change in the number of new COVID-19 cases
may not be an accurate reflection of the true infection rate, as
testing of infection may be different in various countries. An
unbiased estimate of the infection rate will be only possible
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FIGURE 1 | The change in new COVID-19 cases per million population over a 2-month period (1st April and 31st May 2020) plotted against the GDP per capita in 38
European countries. The countries denoted in the figure are: 1: Albania; 2: Andorra; 3: Austria; 4: Belgium; 5: Bosnia and Herzegovina; 6: Bulgaria; 7: Croatia; 8:
Cyprus; 9: the Czech Republic; 10: Denmark; 11: Estonia; 12: Finland; 13: France; 14: Germany; 15: Greece; 16: Hungary; 17: Iceland; 18: Ireland; 19: Italy; 20:
Latvia; 21: Lithuania; 22: Luxemburg; 23: Malta; 24: Montenegro; 25: the Netherlands: 26: Norway; 27: Poland; 28: Portugal; 29: Romania; 30: Russia; 31: Serbia;
32: Slovakia; 33: Slovenia; 34: Spain; 35: Sweden; 36: Switzerland; 37: Ukraine; and 38: the United Kingdom. For example, point 22 is Luxembourg.
TABLE 2 | Regression outcomes: The change in new COVID-19 cases per million
population.
Panel I Panel II Panel III
Change in new Change in new Change in new
COVID-19 cases COVID-19 cases COVID-19 cases
per million per million per million
population population population
GDP per capita −0.810 (0.005)*** −0.801 (0.004)*** −0.878 (0.002)***
Public expenditure
on health
0.164 (0.540) 0.308 (0.296) 0.365 (0.215)
Life expectancy at
birth
– −0.346 (0.060) −0.188 (0.383)
Smoking tobacco – −0.141 (0.390) −0.120 (0.467)
Sanitation facilities – – −0.218 (0.212)
Adjusted R2 0.417 0.440 0.462
F 13.86 8.312 7.017
p 0.000 0.001 0.001
N = 36. Andorra and Bosnia and Herzegovina are excluded due to data unavailability.
p-values are in parentheses. ***Statistically significant at the 1%.
at the end of the pandemic and/or when there are no deaths
reported due to COVID-19. As the data set captured a certain
time interval, the choice of the specified time-period did not take
into account any lockdown effects in each country or the phase of
infection in that country. In addition, the pandemic has carried
on so analysis may be different for different time frames. Future
studies should utilize different time series data in order to provide
longitudinal evaluations.
A further limitation of the present study is that our data were
from European countries. New research should consider other
parts of the world for firm evaluations. In addition, in the present
study, only limited number of available macroeconomic variables
were analyzed. It would of interest to examine whether a country’s
wealth, income distribution, and saving per capita might be
associated with COVID-19 spread. We should emphasize that a
country’s performance is not the only parameter that influences
the spread of COVID-19. Other health and social determinants
should be considered, as well. In the US, Millett et al. (36) found
disproportionately higher rates of COVID-cases and deaths in
black counties compared with other counties. This is also shown
in the UK with higher prevalence of COVID-19 in Black, Asian
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and Minority ethnicities (44). People living in deprived areas
also experienced worse health (45, 46). Hence, it would be of
importance for new research to consider interactions between
economic indicators at a microeconomic and macroeconomic
level and ethnicity, gender, underlying health conditions, labor
characteristics and mobility during the lockdown and their
associations with COVID-19 spread.
Moreover, new studies might examine possible interactions
between GDP per capita and the level of industrial pollution
and urban segregation, and their associations with COVID-19
cases. For instance, in Italy, mortality due to COVID-19 was
found to be higher in areas with higher GDP per capita (41).
The study suggested that adverse environmental factor such as
higher industrial pollution, in addition to the other known risk
factors such as obesity and hypertension, might have driven the
outcomes (41).
It is known that many other factors influenced the rate of
COVID-19 infections. In Wuhan-China, a positive impact of
lockdown was found to restrain further increases of COVID-
19 cases (12). In addition to the social, health and economic
determinants, it is possible that a “level of preparedness” may also
play a significant role in reducing COVID-19 spread. Research
suggests that COVID-19 prevalence and mortality rates were
lower in African and Asian countries compared to certain
Western European countries and the US (47). Several factors
may have contributed to this including early instigation of
lockdown and border closures, younger age of the population,
lack of robust reporting systems, and other unidentified genetic
factors (47). It is possible that some countries might be better
prepared to deal with COVID-19 spread because they have
accumulated experiences from previous pandemics including
SARS. For example, Ghana initiated lockdowns within weeks of
the first COVID-19 cases and was ranked number one among
African countries in administering tests per million people (48).
Fan et al. (49) reporting raw case fatality rate of 53 countries
with the highest COVID-19 death tolls, showed that 43 countries
had lower raw case fatality rate estimates in the second wave of
the COVID-19 pandemic, indicating that healthcare system of
the countries might have been better prepared for the second
phase (49, 50). The theory of better immunity in economically
poor countries was considered by Roy (39) who showed that, in
a sample of 46 countries, although the number of new COVID-
19 cases showed a slight decline in lower-income countries, the
fatality rate was independent of the financial condition of the
countries in question.
Our study shows that GDP per capita might be a critical
epidemiological parameter when comparing different countries
within Europe. We reported a statistically significant negative
association between GDP per capita and the change in new cases
of COVID-19 per million population during the first wave over
a 2-month period (1st April-31st May 2020) in 38 European
countries. The outcomes of this study should call the attention
of policy makers. If better economically performed economies
in Europe display lower susceptibility to pandemics and to
new infections in the early stages of the pandemic, a country’s
economic growth and development should be perceived as a vital
priority for policy makers in future pandemics.
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